Request a Pilot
Technology

From genome to resistance prediction.

The models, pipeline, and platform capabilities behind every BactoAI prediction.

Technology

A modern architecture, purpose-built for genomic AI.

Stage 1
Assembled genome (FASTA)
Stage 2
Feature Extraction
Stage 3
ML Models
Stage 4
Resistance Prediction
Stage 5
Research decision support
PythonMachine LearningBioinformaticsCloud ComputingGenomicsArtificial Intelligence
Platform

Built for clinical labs, researchers, and public health.

AI-powered prediction

Machine learning models trained on curated bacterial genomes.

Whole-genome ready

Accepts assembled genomes in FASTA format.

Fast pipeline

Under 10 minutes from an assembled genome. Sequencing and assembly come first.

Cloud analysis

Upload requires sign-in. Genome files are analysed by our prediction service in the United States and deleted afterwards.

Research reports

Downloadable PDF reports for research decision support.

Web dashboard

It runs in your web browser, so no local setup is needed.

Planned API integration

REST API for LIMS integration is planned.

Surveillance research

Most useful for isolates already sequenced, for example in surveillance.

Research-ready

Export raw predictions for downstream analysis.

Planned on-premises deployment

On-premises deployment is planned.

Privacy first

Designed with Kenya's Data Protection Act, 2019 in mind.

Continuously improved

Models are updated only after independent validation results are reported.

Why BactoAI

BactoAI is a genomic prediction engine and the diagnostic layer other AMR tools build on.

BactoAI is a research prototype that predicts antimicrobial resistance from an assembled bacterial genome. Sequencing and assembly come first. It supports phenotypic susceptibility testing and does not replace it. We are not a lab-logistics or sample-booking marketplace, and not a guideline-based prescribing chatbot. Those tools move samples or protocols faster; BactoAI generates the resistance data point they both depend on.

Lab-booking / logistics tools

Phenotypic testing needs a further 16-20 hours of incubation after isolation.

Prescribing-guideline chatbots

These tools apply WHO or national decision trees to symptoms without organism-specific resistance evidence.

BactoAI genomic prediction

Under 10 minutes from an assembled genome. Sequencing and assembly come first; most useful for isolates already sequenced, for example in surveillance.

For Hospitals

  • Earlier antibiotic decisions
  • Improved antimicrobial stewardship
  • Reduced treatment failure

For Researchers

  • Resistance surveillance
  • Genomic analytics
  • Dataset exploration

For Public Health

  • National AMR monitoring
  • Evidence-driven policy
  • Population surveillance
FAQ

Frequently asked questions

BactoAI is a research prototype that predicts antimicrobial resistance from assembled genomes in FASTA. It supports phenotypic susceptibility testing and does not replace it. Not approved for clinical use.

BactoAI is a research prototype, not approved for clinical use. It supports phenotypic susceptibility testing and does not replace it.